发布时间：

摘要

This report is a detailed market and technology assessment and forecast of the products and technologies in the ablation market for treatment of soft tissues via energy-based modalities, including electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet therapy (hydrotherapy), microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation. The report describes the energy-based technologies in terms of the nature of their effect on soft tissue, the underlying basis of the technology, the requisite systems for their use (including capital equipment, devices and disposables), and their strengths and weaknesses for specific clinical applications. The report details current and anticipated target applications and assesses the current and forecast caseload for each energy-based therapeutic considering competition from any and all alternative energy-based or other therapeutics, with current and worldwide market forecasts (2008-2017) segmented by technology type and specific clinical segment. The report provides segmentation of the worldwide ablation market by both ablation technology and region/country: Americas (USA, Canada, Mexico, Brazil), Europe (Germany, United Kingdom, France, Italy, Spain, BeNeLux), Asia/Pacific (Japan, China, India, Australia) and Rest of World. The report details the current and emerging products, technologies and markets for each energy-based therapy. The report profiles over 60 key companies in this industry detailing their current products, current market position and products under development.

目录及图表

EXECUTIVE SUMMARY
Overview

Trends and Opportunities

Market Leaders

SECTION 1:            ENERGY-BASED THERAPIES BY DISEASE STATE AND TECHNOLOGY
1.1         Cancer
1.1.1         Cryogenic therapy
1.1.2         Microwave therapy
1.1.3         Radiation therapy
1.1.4         Radiofrequency ablation
1.1.5         Stereotactic surgery
1.1.6         Thermal ablation
1.1.7         Laser ablation
1.1.8         Photodynamic therapy
1.1.9         Ultrasonic ablation
1.2         Cardiovascular disease
1.2.1         Angina pectoris
1.2.2         Atrial arrhythmias
1.2.2.1    Laser ablation
1.2.2.2    Cryoablation
1.2.2.3    Electrical cardioversion
1.2.2.4    Microwave ablation
1.2.2.5    RF ablation
1.2.3         Bradycardia
1.2.4         Critical ischaemia
1.2.5         Vascular occlusive disease
1.2.6         Ventricular arrhythmias
1.2.7         Wolf-Parkinson-White Disease
1.3         Elective surgery
1.3.1         Cosmetic surgery
1.3.1.1    Laser hair removal
1.3.1.2    Port wine stains
1.3.1.3    Psoriasis
1.3.1.4    Varicose veins
1.3.2         Ophthalmic surgery
1.3.2.1    Capsulotomy surgery
1.3.2.2    Laser in-situ keratomileusis (LASIK)
1.3.2.2.1    Wave-front guided laser in-situ keratomileusis
1.3.2.3    Laser epithelial keratomileusis (LASEK)
1.4         General surgery
1.4.1    Fecal incontinence
1.4.2    GERD
1.5         Gynecological applications
1.5.1    Hysterectomy
1.5.2    Menorrhagia
1.5.3    Bladder neck suspension
1.5.4    Fibroids
1.6         Urological applications
1.6.1         Urinary tract stones
1.6.2         Benign prostatic hypertrophy
1.6.2.1    TUMT
1.6.2.2    TUNA
1.6.2.3    Vaporization of the prostate (PVP)
1.6.2.4    Water-induced thermotherapy
1.7         Orthopedic applications
1.7.1    Capsular shrinkage
1.7.2    Carpal tunnel syndrome
1.7.3    Chondroplasty
1.7.4    Debridement
1.7.5    Epicondylitis and tendinitis
1.7.6    Inflammatory conditions
1.7.7    Nucleoplasty
Section 2:            PRODUCTS AND TECHNOLOGIES
2.1         Cryogenic energy
2.2         Electrical energy
2.2.1         Implantable cardioverter defbibrillators
2.2.2         Resynchronisation systems
2.2.3         Pacing systems
2.2.4         Pain management
2.3         Hydromechanical energy
2.4         Light energy
2.4.1         Cold lasers
2.4.2         Excimer lasers
2.4.3         Photonic ablation
2.4.4         Ultraviolet B lasers
2.5         Microwave energy
2.6         Radiation energy
2.6.1         Brachytherapy
2.6.2         Radiosurgery
2.6.2.1    Cyberknife
2.6.2.2    Gamma knife
2.7         Radiofrequency energy
2.8         Thermal energy
2.9         Ultrasonic energy
2.6.2.1    Shock wave therapy
2.6.2.2    Ultrasonic surgical systems
 
Section 3:            ABLATION TECHNOLOGIES MARKET
3.1         World market overview
3.2         Market segmentation by product type
3.3         Leading companies in global market
3.4         Major national markets
3.4.1         Americas
3.4.1.1        USA
3.4.1.2        Canada
3.4.1.3        Mexico
3.4.1.4        Brazil
3.4.2         Europe
3.4.2.1        Germany
3.4.2.2        United Kingdom
3.4.2.3        France
3.4.2.4        Italy
3.4.2.5        Spain
3.4.2.6        Benelux countries
3.4.3         Asia/Pacific
3.4.3.1        Japan
3.4.3.2        China
3.4.3.3        Australia
3.4.3.4        South Korea
3.4.3.5        India
3.4.4         Rest of world
Section 4:            COMPANY PROFILES
 

4.1         The Industry
4.1.1             Abla-TX
4.1.1.1         Role in Cancer Treatment
4.1.2             Acoustic MedSystems
4.1.3             Accuray
4.1.4             ACMI/Gyrus/Olympus
4.1.5             AFx (Guidant)
4.1.6             Alcon
4.1.7             American Medical Systems
4.1.8             Angiodynamics
4.1.8.1         Financials
4.1.9            ArthroCare Corporation
4.1.10           AtriCure, Inc.
4.1.11           ATS Medical
4.1.11.1       Financial results
4.1.12           Bard EP
4.1.13           Bausch & Lomb (Warburg Pincus)
4.1.14           Baylis Medical Company
4.1.15           Biosense Webster
4.1.16           Biotronik Inc.
4.1.17           Biowave Corp
4.1.18           Boston Scientific Corp
4.1.18.1       Blazer Cardiac Ablation Catheters
4.1.18.2       Chilli Cooled Ablation Catheters
4.1.18.3       Steerocath-T Cardiac Ablation Catheter
4.1.18.4       Maestro
4.1.18.5       RF 3000® Radiofrequency Ablation System
4.1.18.6       Confient Implantable Cardioverter Defibrillator (ICD)
4.1.18.7       Financials
4.1.19           BSD Medical Corp.
4.1.19.1       MicroThermX-100 Microwave Ablation Systems
4.1.19.2       BSD500 Hyperthermia Systems
4.1.19.3       BSD2000 Hyperthermia Systems
4.1.20           Candela Corp.
4.1.21           Cardima Inc
4.1.22           CardioGenesis Corp
4.1.23           Celon AG
4.1.23.1       Surgery/Radiology
4.1.23.2       Phlebology
4.1.24           Celsion Corp.
4.1.25           ConMed Corp.
4.1.26           Covidien Ltd.
4.1.26.1       Vessel Sealing
4.1.26.2       Electrosurgery
4.1.26.3       Financial Results for fiscal 2007 and 2006
4.1.27           CryoCath
4.1.28           CryoCor, Inc.
4.1.29           CSA Medical Inc.
4.1.30           Cytyc Corp.
4.1.31           Dornier MedTech
4.1.31.1       Compact Delta II
4.1.31.2       Compact Delta II UIMS
4.1.31.3       Compact Sigma
4.1.31.4       Lithotripter S II
4.1.31.5       Medilas D MultiBeam
4.1.31.6       Medilas D FlexiPulse
4.1.31.7       Medilas H 20
4.1.32           EDAP TMS S.A.
4.1.32.1       Financial Update
4.1.33           Elekta
4.1.33.1       Leksell Gamma Knife 4
4.1.33.2       Leksell Gamma Knife 4C
4.1.33.3       Leksell Gamma Knife Perfexion
4.1.34           Endocare
4.1.35           Erbe
4.1.35.1       Electrosurgery
4.1.35.2       Water Jet Surgery
4.1.35.3       Cryosurgery
4.1.36           Ethicon Endo-Surgery Inc.
4.1.37           Galil Medical
4.1.38           Getinge Group
4.1.38.1       Cardiac Surgery
4.1.38.2       Vascular Surgery
4.1.39           HealthTronics Surgical Services
4.1.39.1       Medical Products
4.1.39.2       Urology Services
4.1.40           Medtronic
4.1.40.1       Cardiac Rhythm Disease Management (CRDM)
4.1.40.2       Bradycardia
4.1.40.3       Tachyarrhythmia
4.1.40.4       Ablation Catheters
4.1.41           MedWaves Inc.
4.1.42           Mirabilis Medica
4.1.43           Misonix Inc.
4.1.43.1       Sonablate
4.1.44           NeuWave Medical Inc.
4.1.45           Olympus Medical
4.1.46           OmniSonics Medical Technologies Inc.
4.1.47           PhotoMedex Inc.
4.1.48           PhotoTherapeutics Inc.
4.1.49           PhotoThera Inc.
4.1.50           RFA Medical Inc.
4.1.51           Smith & Nephew
4.1.51.1       Financial Results
4.1.52           Spectranetics
4.1.53           St Jude Medical Inc.
4.1.53.1       Products for Cardiac Rhythm Management
4.1.53.2       Atrial Fibrillation
4.1.53.3       Advanced Neuromodulation Systems
4.1.54           Starion Instruments
4.1.55           Stereotaxis Inc.
4.1.55.1       Stereotaxis Magnetic Navigation System
4.1.56           Theragenics Corporation
4.1.57           Urologix Inc
4.1.57.1       Targis System
4.1.58           USHIFU
4.1.59           Varian Medical Systems Inc.
4.1.59.1       RapidArc
4.1.59.2       Dynamic Targeting Image-Guided Radiation Therapy (IGRT)
4.1.59.3       SmartBeam IMRT
4.1.59.4       Dynamic Adaptive Radiotherapy (DART)
4.1.59.5       IGBT - Image-Guided Brachytherapy
4.1.59.6       Varian Proton Therapy System
4.1.60           VNUS Medical Technologies, Inc.
4.1.60.1       ClosureFAST System
4.1.60.2       Model RFG2 Advanced Radiofrequency Generator
4.1.60.3       Quarterly Financials
APPENDIX:  COMPANY DETAILS

List of Exhibits

Exhibit ES-1: Overview of the Global Ablation and Other Energy-Based Therapies Market by Modality
Exhibit ES-2: Growth of the Worldwide Ablation and Other Energy-Based Therapies Market by Modality
Exhibit ES-3: Worldwide Ablation and Other Energy-Based Therapies Market by Clinical Applicatio
Exhibit ES-4: Market Leaders in Energy-Based Therapies
 

Exhibit 1-1:  Energy-Based Treatment Options for Prostate Cancer

Exhibit 1-2:  Energy-Based Therapies for Cardiovascular Diseases

Exhibit 1-3:  Energy-based Therapies for Atrial Arrhythmias

Exhibit 1-4:  Ventricular Arrhythmia Therapies

Exhibit 1-5:  Energy-based Implants for Ventricular Arrhythmias

Exhibit 1-6:  Cosmetic Lasers

Exhibit 1-7:  Traditional LAVH vs PK LVAH

Exhibit 1-8:  Orthopedic Application of Electrosurgical Devices

Exhibit 1-9:  Collagen Types

Exhibit 1-10:  Chondroplasty Systems’ Zone of Thermal Damage

Exhibit 2-1:  Energy-Based Technologies

Exhibit 2-2:  Cryogenic-Energy Ablation Products

Exhibit 2-3:  Electrical-Energy Ablation Products

Exhibit 2-4:  Hydromechanical Ablation Products

Exhibit 2-5:  Light-Energy Ablation Products

Exhibit 2-6:  Microwave Ablation Products

Exhibit 2-7:  Radiation-Energy Ablation Products

Exhibit 2-8:  Radioactive Seed Products for Brachytherapy

Exhibit 2-9:  Radiofrequency (RF) Ablation Products

Exhibit 2-10:  Thermal-Energy Ablation Products

Exhibit 2-11:  Ultrasound Ablation Products

Exhibit 2-12:  High Growth Applications of Ultrasonic Surgical Systems

Exhibit 3-1:  World Medical Device Market, by Region, 2008

Exhibit 3-2:  World Energy-based Device Market by Product Category, 2007

Exhibit 3-3:  Overview of the Energy-Based Therapies Market by Clinical Application

Exhibit 3-4:  Arrhythmias Treated with Ablation Therapy

Exhibit 3-5:  25-Year Changes in National Mortality Rates Due to Ischaemic Heart Disease

Exhibit 3-6:  Cardiac Angioplasty Procedures Per 100,000 Population, By Country in 2000

Exhibit 3-7:  Cardiac Dysrhythmias and Related Conditions

Exhibit 3-8:  Solid cancers: Ablation Market Potential

Exhibit 3-9:  World Age-Standardize Cancer Incidence per 100, 000 Population (All Ages), by Cancer Type

Exhibit 3-10:  Global Energy-based Therapies Market, by Product Category

Exhibit 3-11:  World Energy-based Device Market by Product Category, 2007 and 2017

Exhibit 3-12:  Ablation and Energy-based Therapeutic Companies by Product Area, Indication and Market Shares, Worldwide, 2008

Exhibit 3-13:  Ablation Market Revenues ($millions), Americas, by Country, 2007-2017

Exhibit 3-14:  Ablation Market Revenues ($000s) US, by Product Segment, 2007-2017

Exhibit 3-15:  Ablation Market Revenues ($000s), Canada, by Product Segment, 2007-2017

Exhibit 3-16:  Ablation Market Revenues ($000s), Brazil, by Product Segment, 2007-2017

Exhibit 3-17:  Ablation Market Revenues ($000s), Mexico, by Product Segment, 2007-2017

Exhibit 3-18:  Ablation Market Revenues ($millions), Europe, by Country, 2007-2017

Exhibit 3-19:  Ablation Market Revenues ($000s), Germany, by Product Segment, 2007-2017

Exhibit 3-20:  Ablation Market Revenues ($000s), United Kingdom, by Product Segment, 2007-2017

Exhibit 3-21:  Ablation Market Revenues ($000s), France, by Product Segment, 2007-2017

Exhibit 3-22:  Ablation Market Revenues ($000s), Italy, by Product Segment, 2007-2017

Exhibit 3-23:  Ablation Market Revenues ($000s), Spain, by Product Segment, 2007-2017

Exhibit 3-24:  Ablation Market Revenues ($000s), BeNeLux, by Product Segment, 2007-2017

Exhibit 3-25:  Ablation Market Revenues ($millions), Asia/Pacific, by Country, 2007-2017

Exhibit 3-26:  Ablation Market Revenues ($000s), Japan, by Product Segment, 2007-2017

Exhibit 3-27:  Ablation Market Revenues ($000s), China, by Product Segment, 2007-2017

Exhibit 3-28:  Ablation Market Revenues ($000s), India, by Product Segment, 2007-2017

Exhibit 3-29:  Ablation Market Revenues ($000s), Australia, by Product Segment, 2007-2017

Exhibit 3-30:  Ablation Market Revenues ($millions), Rest of World, 2007-2017

Exhibit 3-31:  Ablation Market Revenues ($000s), Rest of World, by Product Segment, 2007-2017

Exhibit 4-1:  M&A Activity Among Energy-based Companies

Exhibit 4-2:  AngioDynamics Financial Figures for Fiscal 2007 and 2006

Exhibit 4-3:  ATS Financial Results for Q2 2008 and 2007

Exhibit 4-4:  Boston Scientific Financials, Three Months Ended June 30, 2007 & 2008

Exhibit 4-5:  CardioGenesis Financial Data, 2006 &2007

Exhibit 4-6:  Covidien Ltd Financial Results, 2006 & 2007

Exhibit 4-7: Covidien Medical Device sales by Product Group

Exhibit 4-8:  EDAP TMS Financial Results, 1st Quarter 2008 (to March 31st)

Exhibit 4-9:  Endocare Quarterly Results, 2007 & 2008

Exhibit 4-10:  Medtronic Revenues, 2007

Exhibit 4-11:  Six-month Financial Data for Smith & Nephew, 2007 & 2008

Exhibit 4-12:  TheraGenics Financial Results, Fourth Quarter 2007 and Full Year

Exhibit 4-13:  Varian Medical Systems, Financial Summary, 2005-2007